Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × Endurance Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Inflammation 2 Renal Insufficiency, Chronic 1 Obesity 1 Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Insulin Resistance 1 Glucocorticoid Receptor Deficiency 1 Glioma 1 Breast Neoplasms 1

Interventions

Exercise 24 Metformin 18 Tirzepatide 9 Resistance Training 8 Nutrition Assessment 8 Methods 8 Diet Therapy 8 Diet 8 Counseling 7 Surveys and Questionnaires 6 semaglutide 5 Liraglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Sugars 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03444207 2018-02-23

ENDOFIT

Poznan University of Medical Sciences

Phase NA Completed

Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡